Tom Kraus, ASHP’s vice president of government relations, and Jillanne Schulte Wall, ASHP’s senior director of health and regulatory policy provide an update on the top policy issues impacting pharmacy practice that are being considered by congress and regulatory agencies this month.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physic